Methodological Characteristics of Factor VIII : C Inhibitor Assays and the Availability of Inactivation Treatment

Japanese Journal of Thrombosis and Hemostasis
doi 10.2491/jjsth.19.235
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Japanese Society on Thrombosis and Hemostasis

Related search

Comparison of Clot-Based, Chromogenic and Fluorescence Assays for Measurement of Factor VIII Inhibitors in the US Hemophilia Inhibitor Research Study

Journal of Thrombosis and Haemostasis
MedicineHematology
2013English

Different Impact of Factor VIII Products on Inhibitor Development?

Thrombosis Journal
Hematology
2016English

Improving the Performance of Factor VIII Inhibitor Tests in Hemophilia A

Thrombosis Research
Hematology
2015English

Acquired Factor VIII Inhibitor in a Non-Hemophilic Patient With Chronic Hepatitis C Viral Infection.

Internal Medicine
Internal MedicineMedicine
1999English

Elective Surgery on Factor VIII Inhibitor Patients Using Continuous Infusion of Recombinant Activated Factor VII

Thrombosis and Haemostasis
Hematology
2001English

Long-Term Treatment Course of a Patient With Mild Haemophilia a Who Developed a High Titre Factor VIII Inhibitor

Haemophilia
MedicineGeneticsHematology
2014English

The Impact of Factor VIII/von Willebrand Factor Products in Inhibitor Development and Management of Patients With Hemophilia a With Inhibitors

Oncology & Hematology Review (US)
2007English

A Case of Pancreas Head Cancer With Non-Hemophlic Coagulation Factor-Viii Inhibitor

Japanese Journal of Gastroenterological Surgery
SurgeryGastroenterology
2004English

Combined Deficiency of Factor v and Factor VIII

2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy